FILE - This Aug. 30, 2012 photo shows the exterior of Reliant Stadium before an NFL preseason football game between the Houston Texans and the Minnesota Vikings, in Houston. A fan was taken to a Houston hospital after falling from an escalator at Reliant Stadium. A statement issued by officials of Reliant Park, where the stadium is situated, says the fan fell from the escalator Thursday night, Aug. 30, 2012, while attending a preseason game between the Houston Texans and Minnesota Vikings.(AP Photo/Dave Einsel, File)
FILE - This Aug. 30, 2012 photo shows the exterior of Reliant Stadium before an NFL preseason football game between the Houston Texans and the Minnesota Vikings, in Houston. A fan was taken to a Houston hospital after falling from an escalator at Reliant Stadium. A statement issued by officials of Reliant Park, where the stadium is situated, says the fan fell from the escalator Thursday night, Aug. 30, 2012, while attending a preseason game between the Houston Texans and Minnesota Vikings.(AP Photo/Dave Einsel, File)
FILE - In this April 5, 2012 file photo, people look at a statue of Shannon Stone and his son, Cooper, near the Home Plate gate at Rangers Ballpark in Arlington, Texas. The statue was dedicated to Rangers fans after Shannon Stone died when he fell from the left field stands while reaching for a baseball tossed his way by All-Star outfielder Josh Hamilton. A fan who attended a pre-season Houston Texans' game at Reliant Stadium, Thursday Aug. 30, 2012, fell to his death from an escalator, officials said Friday. (AP Photo/Sharon Ellman, File)
HOUSTON (AP) ? A 25-year-old fan died after tumbling off an escalator from the fifth to ground floor while attending a preseason Houston Texans' game at Reliant Stadium, city police said Friday.
The man fell during the Thursday game between the Texans and the Minnesota Vikings, Reliant Stadium officials said in a statement.
Houston Police Department spokesman John Cannon said he could not identify the man until his family had been informed. He said the circumstances of the fall and what the man was doing at the time were still under investigation. The fan fell from the fifth-floor escalator to the ground floor, Cannon said.
"He was transported to Memorial Hermann Hospital after we had had some fans get the attention of some Houston police officers who were nearby where the body fell," Cannon said.
Police consider the death accidental, Cannon said.
The Houston Medical Examiner's Office confirmed in an email Friday that it had received the body. The medical examiner's website said the man died in a Houston emergency room.
In 2011, a firefighter attending a Texas Rangers game in Arlington died when he fell from the left field stands while reaching for a baseball tossed his way by All-Star outfielder Josh Hamilton.
Shannon Stone fell about 20 feet onto concrete when he tumbled over the left-field railing after catching the ball and falling into an area out of sight from the field as the Rangers faced Oakland. Cooper Stone, his 9-year-old son, witnessed the fall during the second inning.
In April, a statue of Stone and his son was dedicated to Rangers fans in front of the home plate gate at Rangers Ballpark in Arlington. Railings also were raised throughout the ballpark before this season.
__
Associated Press writer Diana Heidgerd contributed to this report from Dallas.
NAPA VALLEY, Calif., Aug. 30, 2012 /PRNewswire/ --?Flavor! Napa Valley 2012 invites festival-goers to take advantage of a variety of ticket options and accommodations from some of the region's top hotels, to create their own ultimate "stay and play" experience during the November 14-18 food, wine and fun extravaganza. With more than 30 events scheduled over the course of five days, a number of Flavor! Napa Valley-themed packages give attendees the opportunity to participate in any number of Flavor! activities, with the option of incorporating a stay at one of the valley's well-appointed havens of privacy, comfort and relaxation. (What could be better after a hard day spent savoring Napa Valley deliciousness?)
*All guests with confirmed reservations at a Napa Valley hotel or inn during this time will automatically receive 20% off of Appellation Trail tickets and select ticket packages.
Ticket and accommodations combination packages include:
Silverado Resort and Spa (Napa) This Flavor! Napa Valley Founding Sponsor is offering a package that includes accommodations in a one-bedroom Fireplace Suite, breakfast for two in The Grill, a signature culinary welcome gift and tickets to First Taste Napa: A Downtown Napa Tasting on Wednesday, November 14.
Napa River Inn (Napa) Tickets to Taste Napa: A Downtown Napa Tasting on November 14th are included in all stays over the festival period at Downtown Napa's Napa River Inn. Quantities are limited and on a first-come, first-served basis. Receive 20% off room rates during the festival, as well as a daily breakfast from Sweetie Pies bakery.
Milliken Creek Inn & Spa (Napa) Guests staying at Milliken Creek between November 1 and 24 for two nights receive a third night at 50% off the best available rate when booking online by entering the promotional code FESTIVAL. Daily gourmet breakfast for two and sunset Magic Hour wine and cheese reception, late-night cordial bar and guest passes to Synergy wellness and fitness center are all included in the rate.
Auberge du Soleil (Rutherford) Join Auberge du Soleil during Flavor! Napa Valley, and enjoy special room rates. For Friday and Saturday night stays, save 10%, and for Sunday through Thursday stays save 20% on room rates. All Flavor! guests will receive a special welcome amenity from the chef and a signature culinary keepsake.
Villagio Inn & Spa and Vintage Inn (Yountville) Mention Flavor! Napa Valley when placing reservations during the festival to receive 20% off of room rates at Villagio Inn & Spa or Vintage Inn. This offer is available from Wednesday, November 14 through November 18, 2012, and includes a number of complimentary amenities such as bottle of wine upon check-in, champagne buffet breakfast, daily afternoon tea and access to Spa Villagio's facilities. Call Reservations at 800.351.1133 for more information and to book.
Hotel Yountville(Yountville) Guests booking a four-night stay during this year's Flavor! Napa Valley festival receive?10%?off regular room rates. Those booking a five-night stay during the festival receive?15%?off of regular room rates. ?All guests enjoy complimentary parking and wireless internet throughout the resort, as well as a complimentary bottle of Napa Valley wine.
Harvest Inn (St Helena) Harvest Inn's exclusive Savor! Napa Valley package puts festival-goers just minutes from festival headquarters, the Culinary Institute of America, and within easy reach of other festival venues throughout Napa Valley. The two-night package includes accommodations in gracious, newly renovated guest rooms, most with a fireplace, daily Napa-style breakfast, a basket filled with wine country treats including a bottle of local wine, a cookbook from the Inn's vast selection and wine tasting for two at two wineries.
Mount View Hotel & Spa (Calistoga) The Mount View Hotel & Spa offers the 'Taste of Calistoga' package for two, which includes one night in a king guestroom, a Couples Mineral Mud Bath, a prix-fixe three course dinner at Barolo Restaurant, winetasting for two at two local boutique wineries, admission for two to the Old Faithful Geyser, continental breakfast in bed and 10% off additional nights. During Flavor! rates per couple start at $348 for stays Monday ? Thursday, and at $398 for stays Friday ? Sunday.
Ticket-only packages include:
Friday of Flavor! (one-day package)
Culinary demonstration with Larry, Brian, Marc and Sean Forgione
Top Taster? blind wine tasting competition
The Appellation Trail: Tasting Napa Valley
Flavor! Foodie (three-day package)
First Taste Napa: A Downtown Napa Tasting
Culinary demonstration with Larry, Brian, Marc and Sean Forgione
The Appellation Trail: Tasting Napa Valley
Culinary Demonstration with Michael Chiarello and Christina Kaelberer
Flavor! Napa Valley Wine Lover (four-day package)
First Taste Napa: A Downtown Napa Tasting
Welcome Dinner
The Appellation Trail: Tasting Napa Valley
Wine Tasting with Kerrin Laz
Wine Tasting with Jon Bonne
Dinner with Napa Valley Winemakers
Terroir to Table?: A Sustainable Brunch
Prices for special Flavor! Napa Valley event ticket packages range from $350-$955 per person. Full descriptions of all events and the packages are available at http://www.flavornapavalley.com.
Flavor! Napa Valley continues to deliver an acclaimed array of Napa Valley and Culinary Institute of America alumni celebrity chefs, restaurants, vintners, sommeliers and artisan food producers offering demonstrations, tastings, dinners, lunches and one-of-a-kind experiences that can be found only in the Napa Valley. Flavor! Napa Valley net proceeds support student programs and scholarships at the CIA at Greystone Campus in St. Helena, Napa Valley.
About Flavor! Napa Valley The 2012 five-day Flavor! Napa Valley? Celebration of Wine, Food & Fun is an annual event featuring world-class Napa Valley wines alongside Napa Valley's master chefs and graduates of The Culinary Institute of America's culinary education programs. Net proceeds from the event support programs and scholarships at The Culinary Institute of America's Greystone Campus in St. Helena. The event is hosted by founding sponsors Silverado Resort and Spa and Dolce Hotels in partnership with Visit Napa Valley, The Culinary Institute of America at Greystone and the Napa Valley Vintners, and is produced by Karlitz & Company. For more details on the festival, including where to stay, please visit www.flavornapavalley.com. Additionally, visit us on Facebook at http://www.facebook.com/FlavorNapaValley, and follow @FlavorNV on Twitter.
Contact:
Tom Fuller & Monty Sander Fuller & Sander Communications tom@fullerandsander.com, 707-253-0868, or monty@fullerandsander.com, 707-253-8503
Margaux Lushing Visit Napa Valley margaux@visitnapavalley.com, 707-260-0114
WASHINGTON (AP) ? A Navy SEAL's firsthand account of the raid that killed Osama bin Laden pulls back the veil on the secret operations conducted almost nightly by elite American forces against terrorist suspects.
Former SEAL Matt Bissonnette's account contradicted in key details the account of the raid presented by administration officials in the days after the May 2011 raid in Abbotabad, Pakistan, that killed the al-Qaida leader, and raised questions about whether the SEALs followed to the letter the order to use deadly force only if they deemed him a threat.
Bissonnette wrote that the SEALs spotted bin Laden at the top of a darkened hallway and shot him in the head even though they could not tell whether he was armed. Administration officials have described the SEALs shooting bin Laden only after he ducked back into a bedroom because they assumed he might be reaching for a weapon.
Military experts said Wednesday that if Bissonnette's recollection is accurate, the SEALS made the right call to open fire on the terrorist mastermind who had plenty of time to reach for a weapon or explosives as they made their way up to the third level of the house where he hid.
Bissonnette wrote the book, "No Easy Day," under the pseudonym Mark Owen as one of the men in the room when they killed bin Laden. The book is to be published next week by Penguin Group (USA)'s Dutton imprint. The Associated Press purchased a copy Tuesday.
For years, the primary weapon in the war on terror has been unmanned drones firing missiles from the sky. But the Bissonnette book reveals a more bloody war waged by special operators, one the public almost never gets to see close up.
The book offers intimate details of a special operations mission. The most memorable scenes are also the most human moments. Bissonnette describes one of the SEALs dressing the wounds of a woman who was shot when she lunged toward the raiders. In another scene, a terrified mother clutches her child, and a young girl identifies the dead man to the SEALs as Osama bin Laden, seemingly unaware of the significance of those words.
In that regard, the bin Laden raid seems destined to become an anachronism. Nearly every top al-Qaida figure killed by the United States since the 9/11 attacks has died in a remote-controlled strike by unmanned drone aircraft ? their deaths seen back in Washington via high-definition video. An estimated 80 top terrorist leaders have been killed in places like Pakistan and Yemen, according to The Long War Journal.com, which tracks such airborne strikes.
Special operations troops often conduct raids similar to the bin Laden strike a dozen times a night in Afghanistan, and previously in Iraq, killing thousands of mostly mid- and lower-level terrorists. It's all part of a war on terror that is winding down and giving way to the drone war outside traditional war zones, given the scheduled drawdown of most U.S. troops in Afghanistan by the end of 2014.
"No Easy Day" shows how routine such operations have become. But the public rarely hears about them. This raid to capture bin Laden, though, was historic.
The SEALS, according to Bissonnette's description, were prepared as they had been in other raids for a gunfight in close quarters, which likely would last only a few seconds, with no margin for error. By the time the SEALs reached the top floor of bin Laden's compound, roughly 15 minutes had passed, giving the terror leader adequate time to strap on a suicide vest or get a gun, he said.
Bissonnette says he was behind the point man going up the stairs in the pitch black hallway. Near the top, he said, he heard two silenced shots fired by the first SEAL into the hallway. He wrote that the SEAL on point had seen a man peeking out of a door on the right side of the hallway, but Bissonnette could not tell from his vantage point whether the bullets hit the target.
The author writes that the man ducked back into his bedroom and the SEALs followed, only to find him crumpled on the floor in a pool of blood with a hole visible on the right side of his head and two women wailing over his body.
Bissonnette says the point man pulled the two women out of the way and shoved them into a corner. He and the other SEALs trained their guns' laser sights on bin Laden's still-twitching body, shooting him several times until he lay motionless.
Once they wiped the blood off his face, they were convinced it was bin Laden.
The SEALs later found two weapons stored by the doorway, untouched, the author said.
National Security Council spokesman Tommy Vietor late Tuesday would not comment on the apparent contradiction between the administration's account and the book's version.
Bissonnette writes that during a pre-raid briefing, an administration lawyer told them that they were not on an assassination mission. According to Bissonnette, the lawyer said if bin Laden did not pose a threat, they should detain him.
"If they didn't feel like there was a threat, they would have captured him," co-author Kevin Maurer told the AP on Wednesday. "But from when they first hit the ground, all the way until they got to the third deck, they had encountered armed men, which made the use of force essential," said Maurer, a former AP reporter.
A former deputy judge advocate general for the Air Force defended the decision to shoot the man the SEALs saw in the hallway.
"In a confined space like that where it is clear that there are hostiles, the SEALs need to take reasonable steps to ensure their safety and accomplish the mission," said the former JAG, retired Maj. Gen. Charlie Dunlap, who now teaches at Duke University law school.
Bissonnette writes that none of the SEALs were fans of President Barack Obama and knew that his administration would take credit for ordering the raid. One of the SEALs said after the mission that they had just gotten Obama re-elected by carrying out the raid. But he says they respected him as commander in chief and for giving the operation the go-ahead.
In an interview scheduled to air Sunday on CBS' "60 Minutes," Bissonnette said the book was "not political whatsoever" and not timed to influence the upcoming national elections. He said it was to commemorate the Sept. 11, 2001, terror attacks and credit those whose work made the mission to get bin Laden a success.
"My worry from the beginning is, you know, it's a political season. This book is not political whatsoever. It doesn't bad-mouth either party, and we specifically chose Sept. 11 to keep it out of the politics. If these ? crazies on either side of the aisle want to make it political, then shame on them."
CBS said Bissonnette was disguised and his voice altered for the interview. The network used only his pseudonym and not his name.
The Pentagon and the CIA, which commanded the mission, are examining the manuscript for possible disclosure of classified information, and could take legal action against Bissonnette.
In a statement provided to the AP, the SEAL author says he did "not disclose confidential or sensitive information that would compromise national security in any way."
The book does include information not previously reported about specific CIA officers' involvement in the raid.
Bissonnette's real name was first revealed by Fox News and confirmed to the AP.
Jihadists on al-Qaida websites have posted purported photos of the author, calling for his murder.
___
Associated Press writers Matt Apuzzo and Adam Goldman contributed to this report.
___
Follow Kimberly Dozier on Twitter: http://es.twitter.com/KimberlyDozier
Robert Rowley, MD, Healthcare and health IT consultant, practicing family physician
Patient-facing health IT has come a long way, but is also poised to make another significant leap forward. Last week, the final rules for Stage 2 Meaningful Use were released, and even though these rules address what physicians and hospitals must do to receive incentive payments for demonstrating ?meaningful use of certified healthcare technology,? some of these rules impact how patient-facing technology (PHRs, or Personal Health Records) will evolve.
The new Stage 2 rules won?t come into play until 2014, but they signal how patient-facing technology will be influenced by Electronic Health Records (EHRs). Two of the new core criteria address patient engagement: providing patients with online access to their health information, and providing secure messaging between patients and providers. There are minimum thresholds for each of these (5%), meaning that actual patient engagement is something that physicians must demonstrate in order to be eligible for Stage 2 Meaningful Use money.
Even though these rules put pressure on providing patient-facing portals to a physician?s EHR, the initiative is still physician (or health system) centered. It is worthwhile to examine the state of patient-facing health IT from a patient-centric perspective, and outline a new vision for this area of technology ? one which must come, regardless of the Meaningful Use program.
The new PHR dilemma ? too many portals Legacy PHRs emerged in the mid-2000s, and were disconnected, free-standing products that patients could sign up for directly. Notable giants in this field were Microsoft?s Health Vault and Google Health, though many other companies emerged at the time (now all gone). They had a great vision ? a personal record of health that was longitudinal, attached to a patient rather than a doctor, and were something you could take with you as you navigated through the health system.
Connectivity was limited and setup proved difficult. This was at a time when few physicians had EHRs (adoption of EHRs by physicians at the time was <7%), and so the main data sources available were hospitals, health plans and labs. What did emerge from these products was exposure of how inaccurate such data sources were (the e-Patient Dave experience). Not surprisingly, these products suffered from low adoption and engagement, and almost all of them have vanished from the horizon.
The current generation of PHRs is tethered to a data source, and automatically populated by that data source. Three different kinds of data sources exist, and thus we have 3 different kinds of products (and product-development thinking):
Portals to EHRs. This is what one usually thinks about when ?PHR? is mentioned in a modern context. The data resides in a physician?s (or hospital?s) EHR system, and segments of that data are exposed via a portal. Some are quite sophisticated, and allow good two-way communication with the doctor?s office, viewing one?s health data found in the doctor?s system, and uploading one?s past medical history. Stage 2 of Meaningful Use will require that all certified EHRs have this capability.
Portals to employer wellness (or Third Party Administrator) data. There are also some good patient portals out there, showing employer, health plan and lab data. A good example here is Dossia, which is an employer consortium that hosts a patient portal for employee wellness. These portals are separate from EHR data, just like how employer wellness programs have been separate from traditional health care (sickness care).
Consumer sites, with device or self-entered data. These are generally web sites that contain consumer-derived data, and are socially sharable. The data is outside the reach of HIPAA (it is created by consumers themselves, and not by health care providers), and has enjoyed popularity precisely because it is socially sharable ? witness Facebook apps like RunTracker, or FitBit pedometers. Such sites are popular among fitness enthusiasts, runners, etc. Engagement here is pretty high.
So here is the dilemma of modern PHRs: now that most physicians have EHRs (over 60% state they have now have some form of EHR in their practice), consumers are facing the problem of multiple logins needed for multiple portals, one for each doctor with an EHR (not to mention any employer-based portals). This was not an issue a few years ago, when few doctors had EHRs, but that has changed.
This is a step forward ? patient data is more accurate (the EHR data that physicians use in their own records is clinically-derived, not billing-derived). But the segmented, siloed nature of health data becomes apparent when a patient is faced with many tethered-PHR logins to each segment of their overall health story. Very chaotic (just like health care itself).
A new vision ? the Universal PHR Clearly, then, we have a need for a unified personal health record that can combine all the different data sources in one central place, yet behave as though it were tethered to each. This would re-capture the original vision of legacy PHRs (perhaps it was a concept before its time, before the tide to ubiquity of EHRs had risen), by being patient-owned and portable. A cradle-to-grave record that you could take with you as you changed doctors, health insurance, employers, etc., yet be easily connected with the various parts of the health care system you were engaging at the time ? that is the new vision.
Where might such a newly-envisioned technology emerge? From EHRs that already have patient portals (PHRs tethered to their own EHR product)? From employer-based wellness portals who are thus not indebted to any specific EHR (but are not connected to any, either)? From a new company altogether?
My sense is that such a Universal PHR will not come from an EHR vendor, as their focus and vision is centered around physician (or hospital) workflows, as it should be, and not on a patient-centered product. In fact, the tendency of some EHR vendors to create products that are ?walled gardens? is a problem that can get in the way of an external, portable Universal PHR.
The strategic issues and challenges are significant. But we are at a stage of health IT connectivity where such a product is possible, and in fact is the imperative for the next generation of patient-facing health IT. Data-format standardization from EHRs (as is specified in the Stage 2 Meaningful Use regulations), the increasing use of EHRs by doctors and hospitals, and the emergence of Health Information Exchanges (both public/regional as well as health-system-confined private ones) all point to a feasibility that was not previously present.
This is an area that I am becoming very interested in focusing upon. I think it is the next ?big thing? in health IT, and will be exciting to watch it develop.
Robert Rowley is a practicing family physician and healthcare information technology consultant. From its inception through 2012, Dr. Rowley had been Practice Fusion?s Chief Medical Officer, having created the underlying technology in his own practice, and using that as the original foundation of the Practice Fusion web-based EHR. This article was?first published?on?Dr. Rowley?s web site?www.robertrowleymd.com.
Tags: Google Health, Health IT, Microsoft Health Vault, Patient Engagement, Patient Portals, PHRs, Robert Rowley, Stage 2 Meaningful Use
LAPLACE, La. (AP) ? The state sent scores of buses and dozens of high-water vehicles to help evacuate about 3,000 people from St. John the Baptist Parish after Tropical Storm Isaac pushed water from lakes Pontchartrain and Maurepas into parts of LaPlace.
Rising water closed off all main thoroughfares into the parish, which is about 30 miles west of New Orleans. In many areas, water lapped up against houses and left cars stranded. The water was being driven higher by south winds as Isaac passed to the west and was expected to continue rising through the night.
Floodwaters rose waist-high in some neighborhoods, and the Louisiana National Guard was working with sheriff's deputies to rescue people stranded in their homes and surprised by the flooding.
The floodwaters "were shockingly fast-rising, from what I understand from talking to people. It caught everybody by surprise," Lt. Gov. Jay Dardenne said.
By 8 p.m. about 1,500 people had been evacuated, most to a nearby church being used as a temporary shelter, and Gov. Bobby Jindal's office said up to another 1,500 more were expected to leave their homes.
Dardenne said officials speculated that the fortifying of levees in other parishes along Lake Pontchartrain after Hurricane Katrina forced storm surge into new areas that had escaped flooding in past storms.
"The water's got to go somewhere, and this is where it went," he said.
The Department of Wildlife and Fisheries had 30 boats in LaPlace and 20 more on the way to get people out of their homes, and the state sent 89 buses to take them to shelters in Alexandria and Shreveport, and to evacuate an assisted living facility. The National Guard had seven high-water vehicles in the parish and another 25 ? as well as ten boats ? on the way Wednesday night to assist the parish evacuation efforts.
With one water district flooded, the National Guard also was sending two 5,000-gallon water tankers and 35,000 bottles of water to distribute to residents. State officials sending 200 one-ton sandbags to protect the water system from floodwater contamination.
My family takes a lot of road trips. With many friends and family members within a day?s driving distance from our home in West Virginia, we?re on the road quite a bit.
Besides putting miles on our vehicle, road trips are a fantastic way for our family to bond. And by ?bond? I really mean confine ourselves to tight quarters and try not to lose our tempers while still getting where we need to go and Why on earth did we plan this roadtrip again?
With music snobs for parents and children ages 9, 5, and 3, it can be a challenge to find music that we all agree on. Here are our time-tested favorites.
Here Come the ABCs
They Might be Giants have produced so many great children's CDs, and this is one of our favorites.
This songbook-CD pack is filled with whimsical tunes that you and your toddler will love. It's an interactive CD that will get you moving on those long drives to grandma's!
Do you know about Elizabeth Mitchell? If you have a toddler, you absolutely should. Her songs are sweet and well-written and your kiddo will love them, I promise!
This CD is comprised of wonderful covers of Muppets songs, some better-known than others. My kids love "Mahna Mahna" by The Fray and "Our World" by My Morning Jacket the most.
Dan Zanes doesn't make "typical" children's music, and this difference is one of the reasons he's a hit with my family. The songs on Catch that Train are great for roadtrips because they do not all sound alike; it's enough to keep even the littlest members of the family engaged.
Mary Lauren Weimer?is a social worker turned mother turned writer. Her blog,?My 3 Little Birds, encourages moms to put down the baby books for a moment and tell their own stories. Connect with her on?Facebook?and?Twitter.
More by Mary Lauren:
10 Ideas For Backyard Toddler Fun
Family Biking with your Toddler: Tips from the Pros!
Home is among the most beautiful place and favorite place for anyone. It is a place when a family or person resides. People will build their home based on their requirements. People have to decor their home along with best home improvement appliance. Home enhancement is nothing but generating some changes to existing one just like curtains for glass windows, furniture for home and also etc.
So, seeking the great home appliance is little bit tricky. Here?s solution for that; Lowes will be the one of the leading home improvement equipment retailer in People. It is chain based retailer. It was founded in 1946 North Wilkesboro, Nc.Lowe?s Companies, Inc. get chain of stores 1710 stores in Us all and 20 throughout Canada. Lowes is the subsequent largest hardware sequence.
Now a day?s online purchasers tend to be showing interest to purchase products online since it saves money and time. Thus, Lowes also have website and they offer lowes coupons or Lowes promotional codes for users to grab lots of bucks in home improvement appliance. You can find latest and new appliance for home from Lowes like Garden facilities (Plants, tools, arbors, backyard accessories), Appliances (Refrigerators, Refrigerators, washers & blow dryers and etc),Bath Accessories, Building companies, cleaning and firm, Electrical (switches, shops, dimmers and etc),Equipment, kitchen, Home decor water system, windows and more. It provides wide range of home building as well as home decor materials. Here is the best place to buy home development appliance.
Here you?ll find all indoor and outdoor components like plants, seats, furniture and more with great price. Lowes discount codes are best way to save cash home appliances. Here you can find all modern as well as designer bed and bath appliances, home decoration and furniture, flooring and kitchen and much more.
Find and use Lowes voucher codes to get offers such as get 10% Off upon Major Appliances purchases over $299 , Buy 2 acquire 1 free about Purchase of Solar Landscape Lights, Free Shipping on purchases over $49, Sign up and have 5% off on Lowes Plastic card and more. So, get pleasure from never ending savings in home appliances by using Lowes Promo codes and Lowes Coupons.
Shop Online together with Lowes Promotional codes for huge collection of appliances, coloring, patio furniture, tools, floor, hardware, Home Appliances, Creating Supplies, Doors, Floors, Hardware, Lighting along with Fans and more in Lowes to get discounts and provides. Enjoy shopping.
For more information about lowes coupons please visit the website.
A movie about a former smuggler who starts a night club (in space!), "Pluto Nash" is not only one of August's worst flops ever, but one of the biggest box-office busts of all time: It had production costs of about $120 million and only $7 million in worldwide profits. You do the math.
'The Astronaut's Wife' (1999)
Johnny Depp! Charlize Theron! "The Astronaut's Wife" had to be a success, right? Wrong. Unfortunately, this stale 1999 thriller, about an astronaut (Depp) who starts acting strange after returning from space (Spoiler alert: He's possessed by an alien!), ended up grossing just under $20 million on a $75 million budget.
'The Fan' (1996)
Audiences had no interest in seeing Robert De Niro as an obsessed baseball fan in this far-fetched 1996 flick. Not even Wesley Snipes' star power (at the time, anyway) could save the film's box office return: $18 million on a $55 million budget.
'Gigli' (2003)
It should be no surprise that one of the worst movies ever was also one of history's biggest flops. In the end, this 2003 flick, starring Ben Affleck as a mobster who's forced to kidnap the mentally challenged younger brother of a federal prosecutor (yeeesh), grossed only $7.3 million to its $70 million budget.
'The Meteor Man' (1993)
Only a handful of filmmakers have been able to successfully write, direct, produce and star in their own movies. Robert Townsend found this out the hard way with "The Meteor Man," a film about a superhero who develops powers after being struck by a meteor. With an estimated $30 million budget, the flick brought in only $8 million in ticket sales.
'The Garbage Pail Kids' (1987)
A movie based on a series of trading cards? That sounds like an idea Hollywood would have today. Alas, this film hit theaters in 1987 and grossed an abysmal $1.8 million on a $30 million budget. (Also, what the hell did they spend $30 million on?!)
'Dudley Do-Right' (1999)
Sure, a spinoff for a "Rocky and Bullwinkle" character -- particularly one about a doltish Canadian Mountie -- seems like a decent idea. Unfortunately, this 1999 comedy starring Brendan Fraser fell completely flat, bringing in almost $10 million on a $70 million budget.
'Osmosis Jones' (2001)
A cast that included Bill Murray, Chris Rock, William Shatner and Laurence Fishburne didn't stop this part-animated, part-life action flick from ending up on the list. Despite a $70 million budget, "Osmosis" brought in a measly $14 million in ticket sales.
'Little Nemo: Adventures in Slumberland' (1992)
Originally released in Japan, "Nemo" bombed at the U.S. box office, bringing in $11.4 million in ticket sales (this despite generally positive reviews from critics).
'Event Horizon' (1997)
Coming off the success of "Mortal Kombat," director Paul W.S. Anderson turned to the future, with the film "Event Horizon." Unfortunately, the movie didn't pan out nearly as well as "Kombat," making back less than half of its $60 million budget.
'Shanghai Surprise' (1986)
Good news: This movie was nominated for a ton of awards. Bad news: Those awards were Razzies. Yes, this 1986 film starring Sean Penn and Madonna as two newlyweds living in China is as bad as it sounds (Madge was awarded the Worst Actress of the year.) "Shanghai" went on to gross $2.3 million from its $17 million budget.
'The Great Raid' (2005)
The poster for this film boasts "The most daring rescue mission of our time." Too bad no one came out to witness it. Starring Joseph Fiennes and James Franco, "The Great Raid" grossed $10.8 million on a huge $80 million budget.
'The 13th Warrior' (1999)
Movies based on Michael Crichton novels are usually hit or miss at the theater. In the case of "The 13th Warrior," it was the latter: This 1999 historical fiction flick, starring Antonio Banderas as an emissary who joins a band of Norse warriors, made $61.7 million in ticket sales, well below its eye-popping $160 million budget.
'Kull the Conqueror' (1997)
What was originally intended to be a third "Conan" movie (that is until Arnold Schwarzenegger refused to reprise his role) turned into a spinoff featuring lesser known barbarian Kull. Sorry, Kevin Sorbo, but your action skills are no good here: The film's $30 million budget netted a paltry $6.1 million at the box office.
'Honky Tonk Freeway' (1981)
As the folks behind 1981's "Honky Tonk Freeway" found out, not all British comedy translates overseas. This costly flop is consider one of the worst in movie history, making $2 million on a $24 million budget.
'Christopher Columbus: The Discovery'
Marlon Brando had a string of flops at the end of his career, including this underwhelming 1992 film about the events leading up to Columbus's trip to the New World. Despite Brando being cast as the Grand Inquisitor Tom?s de Torquemada -- and Tom Selleck as King Ferdinand V (um, what?) -- "The Discovery" made $8.3 million off its $45 million budget.
'The Stupids' (1996)
John Landis may be one of the best comedy directors ever, but even he couldn't prevent this 1996 film from posting a terrible return. Based on the famous "Stupids" books by Harry Allard, the Tom Arnold-starring movie made $2.4 million in ticket sales on a $25 million budget.
Police stand at Earls Hall Farm in St Osyth, southern England where a lion was apparently seen Monday Aug. 27, 2012. Outside the idyllic English village of St. Osyth, police are hunting a lion. A small army of officers and tranquilizer-toting zoo experts, along with a pair of heat-seeking helicopters, are spending their Monday combing the woods, ponds, and farmland around the coastal community after a resident spotted what was believed to be a lion lounging in a field of grass. Where such a beast may have come from is anyone's guess; the local zoo says its animals are accounted for, and police have said a local circus isn't missing any either. (AP Photo/Steve Parsons/PA Wire) UNITED KINGDOM OUT
Police stand at Earls Hall Farm in St Osyth, southern England where a lion was apparently seen Monday Aug. 27, 2012. Outside the idyllic English village of St. Osyth, police are hunting a lion. A small army of officers and tranquilizer-toting zoo experts, along with a pair of heat-seeking helicopters, are spending their Monday combing the woods, ponds, and farmland around the coastal community after a resident spotted what was believed to be a lion lounging in a field of grass. Where such a beast may have come from is anyone's guess; the local zoo says its animals are accounted for, and police have said a local circus isn't missing any either. (AP Photo/Steve Parsons/PA Wire) UNITED KINGDOM OUT
LONDON (AP) ? So, were the locals lying about the lion?
Police said Monday that they've found no evidence to support area residents' claims that they'd spotted a big cat prowling the countryside near the idyllic village of St. Osyth, in the southeastern English county of Essex.
Sunday's reported sightings alarmed many of the village's 4,000 people, and authorities sent about 40 officers, tranquilizer-toting zoo experts, and a pair of heat-seeking helicopters to the area in an effort to find the beast.
But a police spokeswoman said that, after an extensive search, "we've found no evidence" of a lion. The creature spotted Sunday night may have been a large domestic cat or a wildcat, she added.
So does that mean there never was any lion?
The official, who spoke on customary condition of anonymity, demurred, noting that the people interviewed by police were convinced they'd spotted a lion. That aside, she said, "we've stopped searching for it."
It seems the mysterious "Essex Lion" will join a number of other mythical beasts that at times appear and then disappear into Britain's forests and seaside ? particularly in the dead of summer, when journalists struggle to fill papers and news bulletins.
The best-known mystery big cat in Britain was the "Beast of Bodmin," a panther that was allegedly spotted so many times that it prompted a government probe into the matter. The 1995 investigation concluded there was no evidence of exotic large cats roaming the nation's countryside.
In 2011, there was the Hampshire White Tiger, whose alleged appearance near a sports field stopped a cricket game and led to a police alert (the tiger turned out to be a stuffed toy).
And in 2007, the British media went wild over a man who claimed to have photographed a great white shark off the coast of Cornwall, in southwestern England. The man, a bouncer, later admitted that the pictures were actually taken while on vacation in South Africa, adding that he couldn't believe anyone had been foolish enough to take the hoax seriously.
CRT consensus set to standardize and improve care for patients worldwidePublic release date: 28-Aug-2012 [ | E-mail | Share ]
Contact: Jacqueline Partarrieu press@escardio.org 49-176-105-72407 European Society of Cardiology
Cardiac resynchronization therapy (CRT) has risen in popularity, with more than 200,000 devices implanted worldwide last year and more than one million over the last 10 years
Munich, Germany August 28 2012: Recommendations for the practical management of CRT patients have been set out for the first time in an international consensus statement on cardiac resynchronization therapy (CRT) in heart failure.
The 2012 Expert Consensus Statement on Cardiac Resynchronization Therapy (CRT) in Heart Failure: Implant and Follow-up Recommendations and Management was developed by the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS) in the US, and will be published in their respective journals, EP Europace and HeartRhythm.
CRT was developed 20 years ago in Europe and the United States and has reached maturity as a major heart failure therapy. The therapy has risen in popularity, with more than 200,000 devices implanted worldwide last year and more than one million over the last 10 years.
The clinical indications for CRT are clearly outlined in the 2007 ESC guidelines, which were updated in 2010, and US guidelines from 2008. These guidelines are supported by robust evidence from randomised clinical trials.
This consensus statement is particularly unique because it incorporates expert consensus from Europe and North America.
"We have very strong recommendations regarding clinical indications based on the clinical evidence and these are covered in multiple guidelines," said Professor Jean-Claude Daubert, joint task force co-chair and Professor of Cardiology and Vascular Diseases, University of Rennes 1, France. "CRT therapy improves symptoms, cardiac function, hospitalization rates and mortality in a broad range of patients with heart failure."
He added: "On the contrary, until now we did not have a consensual document on the practical aspects of this therapy. Our goal was to establish a consensus statement on how to manage CRT patients before, during and after the implantation procedure. We do not discuss clinical indications."
"In this document we attempted to fill in the gaps in clinical evidence and provide practical recommendations for the evaluation and management of the CRT patient that could be applied to patients implanted anywhere in the world," said Dr Leslie Saxon, US joint task force co-chair and Chief, Division of Cardiovascular Medicine, University of Southern California.
While there are some randomised trials on specific practical aspects of CRT, there was a lack of solid clinical evidence for all aspects of management. For this reason, experts from both sides of the Atlantic teamed up to establish a clinical consensus on how to manage the CRT patient.
The document is in six sections:
Pre-implant evaluation
Includes recommendations on how to manage patients just before CRT implantation. This section focuses on potential temporary contraindications to the intervention, and how to manage medications, particularly anticoagulants and antibiotics, just before and during the implantation procedure. Professor Daubert said: "There was no consensus before on these very particular aspects."
CRT implantation
How to implant the CRT device. This section describes all steps of the procedure such as anaesthesia, lead implant sequence, left ventricular lead placement and defibrillation testing. "This is, to my knowledge, the first attempt to write a consensus definition of the optimal way to implant a CRT device," said Professor Daubert. "We make recommendations on all the technical aspects of the implantation procedure."
Pre-discharge evaluation and device programming
Includes how to recognise and handle acute complications, initial programming of the device just after the operation and before hospital discharge, and atrioventricular (AV) and ventriculoventricular (VV) optimization. "This is the first time we have a consensus on the optimal programming of the CRT device just after the operation," said Professor Daubert.
CRT follow-up
This section outlines how follow-up should be organised and what assessments should be made. The complementary role of remote monitoring is discussed, with a special focus on how remote hemodynamic monitoring can be used. The need for strong cooperation between the heart failure specialist and the electrophysiologist (EP) is stressed. "We have to keep in mind that the CRT patient is primarily a heart failure patient," said Professor Daubert. "Follow-up has to concern not only the technical follow-up of the device, but also and primarily the heart failure status of the patient. It is essential to optimise the heart failure management of the patient."
Response to CRT management of the non-responder
Discusses how to assess the response to CRT and how to manage non-responders. The document recommends that a systematic assessment should be conducted to identify and treat reversible causes of non-response.
Special considerations
Includes recommendations for the management of CRT in particular situations such as patients with atrial fibrillation and patients on renal dialysis. Also discussed are how to choose between the two types of device resynchronization alone or resynchronization plus defibrillation and the relative advantages and disadvantages of each. And finally, issues related to end of life, patient education and engagement, and cost effectiveness are considered.
Professor Daubert concluded: "This is the first consensus statement on all of the practical aspects involved in managing CRT patients throughout their entire journey on CRT therapy. We hope it will be useful in the clinical practice of physicians all over the world who use this type of therapy, including heart failure specialists who refer and follow patients and EP specialists who implant the device and follow patients."
###
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
CRT consensus set to standardize and improve care for patients worldwidePublic release date: 28-Aug-2012 [ | E-mail | Share ]
Contact: Jacqueline Partarrieu press@escardio.org 49-176-105-72407 European Society of Cardiology
Cardiac resynchronization therapy (CRT) has risen in popularity, with more than 200,000 devices implanted worldwide last year and more than one million over the last 10 years
Munich, Germany August 28 2012: Recommendations for the practical management of CRT patients have been set out for the first time in an international consensus statement on cardiac resynchronization therapy (CRT) in heart failure.
The 2012 Expert Consensus Statement on Cardiac Resynchronization Therapy (CRT) in Heart Failure: Implant and Follow-up Recommendations and Management was developed by the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS) in the US, and will be published in their respective journals, EP Europace and HeartRhythm.
CRT was developed 20 years ago in Europe and the United States and has reached maturity as a major heart failure therapy. The therapy has risen in popularity, with more than 200,000 devices implanted worldwide last year and more than one million over the last 10 years.
The clinical indications for CRT are clearly outlined in the 2007 ESC guidelines, which were updated in 2010, and US guidelines from 2008. These guidelines are supported by robust evidence from randomised clinical trials.
This consensus statement is particularly unique because it incorporates expert consensus from Europe and North America.
"We have very strong recommendations regarding clinical indications based on the clinical evidence and these are covered in multiple guidelines," said Professor Jean-Claude Daubert, joint task force co-chair and Professor of Cardiology and Vascular Diseases, University of Rennes 1, France. "CRT therapy improves symptoms, cardiac function, hospitalization rates and mortality in a broad range of patients with heart failure."
He added: "On the contrary, until now we did not have a consensual document on the practical aspects of this therapy. Our goal was to establish a consensus statement on how to manage CRT patients before, during and after the implantation procedure. We do not discuss clinical indications."
"In this document we attempted to fill in the gaps in clinical evidence and provide practical recommendations for the evaluation and management of the CRT patient that could be applied to patients implanted anywhere in the world," said Dr Leslie Saxon, US joint task force co-chair and Chief, Division of Cardiovascular Medicine, University of Southern California.
While there are some randomised trials on specific practical aspects of CRT, there was a lack of solid clinical evidence for all aspects of management. For this reason, experts from both sides of the Atlantic teamed up to establish a clinical consensus on how to manage the CRT patient.
The document is in six sections:
Pre-implant evaluation
Includes recommendations on how to manage patients just before CRT implantation. This section focuses on potential temporary contraindications to the intervention, and how to manage medications, particularly anticoagulants and antibiotics, just before and during the implantation procedure. Professor Daubert said: "There was no consensus before on these very particular aspects."
CRT implantation
How to implant the CRT device. This section describes all steps of the procedure such as anaesthesia, lead implant sequence, left ventricular lead placement and defibrillation testing. "This is, to my knowledge, the first attempt to write a consensus definition of the optimal way to implant a CRT device," said Professor Daubert. "We make recommendations on all the technical aspects of the implantation procedure."
Pre-discharge evaluation and device programming
Includes how to recognise and handle acute complications, initial programming of the device just after the operation and before hospital discharge, and atrioventricular (AV) and ventriculoventricular (VV) optimization. "This is the first time we have a consensus on the optimal programming of the CRT device just after the operation," said Professor Daubert.
CRT follow-up
This section outlines how follow-up should be organised and what assessments should be made. The complementary role of remote monitoring is discussed, with a special focus on how remote hemodynamic monitoring can be used. The need for strong cooperation between the heart failure specialist and the electrophysiologist (EP) is stressed. "We have to keep in mind that the CRT patient is primarily a heart failure patient," said Professor Daubert. "Follow-up has to concern not only the technical follow-up of the device, but also and primarily the heart failure status of the patient. It is essential to optimise the heart failure management of the patient."
Response to CRT management of the non-responder
Discusses how to assess the response to CRT and how to manage non-responders. The document recommends that a systematic assessment should be conducted to identify and treat reversible causes of non-response.
Special considerations
Includes recommendations for the management of CRT in particular situations such as patients with atrial fibrillation and patients on renal dialysis. Also discussed are how to choose between the two types of device resynchronization alone or resynchronization plus defibrillation and the relative advantages and disadvantages of each. And finally, issues related to end of life, patient education and engagement, and cost effectiveness are considered.
Professor Daubert concluded: "This is the first consensus statement on all of the practical aspects involved in managing CRT patients throughout their entire journey on CRT therapy. We hope it will be useful in the clinical practice of physicians all over the world who use this type of therapy, including heart failure specialists who refer and follow patients and EP specialists who implant the device and follow patients."
###
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
ASH honors David Ginsburg, M.D., and Richard Aster, M.D., with 2012 Henry M. Stratton MedalPublic release date: 27-Aug-2012 [ | E-mail | Share ]
Contact: Claire Gwayi-Chore cgwayi-chore@hematology.org 202-776-0544 American Society of Hematology
The Henry M. Stratton Medal is named after the late Henry Maurice Stratton, co-founder of Grune and Stratton, the medical publishing house that first published ASH's journal Blood. The prize honors senior investigators whose contributions to hematology are well-recognized and have taken place over a period of several years. This year, for the first time, the Stratton Medal will be awarded to two individuals, one in basic research and the other in clinical/translational research. Dr. Ginsburg will receive the 2012 Stratton Medal for Basic Research for his many seminal scientific contributions in characterizing the molecular and genetic basis of inherited bleeding and clotting disorders. Dr. Aster will receive the 2012 Stratton Medal for Clinical/Translational Research for his many breakthroughs in platelet immunology, mainly in drug-induced antibodies, human leukocyte antigen anti-platelet antibodies, and neonatal thrombocytopenia.
Dr. Ginsburg is the James V. Neel Distinguished University Professor of Internal Medicine, Human Genetics, and Pediatrics at the University of Michigan and an Investigator of the Howard Hughes Medical Institute. Dr. Ginsburg has dedicated his medical career to understanding the clotting system and has made many contributions to the field of hematology, including identifying the genetic basis of numerous clotting disorders, such as thrombotic thrombocytopenic purpura (TTP), combined deficiency of Factor V and Factor VIII, and von Willebrand disease (VWD). Beginning with the cDNA cloning of VWF in 1985, Dr. Ginsburg and his colleagues demonstrated how different mutations in the VWF gene resulted in the variable subtypes of VWD, a focus which also led to his group's identification and cloning of the ADAMTS13 gene as the cause of TTP.
A member of ASH since 1985, Dr. Ginsburg has served in numerous roles within the Society, including serving as Chair of the Committee on Scientific Affairs, Councillor on the Executive Committee, and a member of the Scientific Subcommittee on Hemostasis (now the Scientific Committee on Hemostasis) and the Scientific Committee on Thrombosis and Vascular Biology.
The quality and impact of Dr. Ginsburg's research have been recognized by numerous prestigious honors and awards. In addition to receiving ASH's 2000 E. Donnall Thomas Lecture and Prize, Dr. Ginsburg is an inductee of the Institute of Medicine and National Academy of Sciences and has been honored with the National Institutes of Health (NIH) Merit Award, the American Heart Association Distinguished Scientists Award, and the American Society for Clinical Investigators ASCI/ Stanley J. Korsmeyer Award. Dr. Ginsburg's scientific contributions are only a part of his overall impact on the field of hematology. Another important facet of his contributions is evidenced by the numerous scientists and clinicians that he has mentored over the years, many of whom have made remarkable discoveries in hematology.
Dr. Aster is a Professor of Medicine at the Medical College of Wisconsin and Senior Investigator at the Blood Research Institute of the Blood Center of Wisconsin. As the CEO of the BloodCenter for more than 25 years, Dr. Aster transformed the then local Blood Center of Southeastern Wisconsin into one of the world's premier academic hematology and transfusion medicine research institutes and the top NIH-funded blood center in the country.
During his more than 40-year career Dr. Aster has been continuously recognized as a scientific leader in hematology and transfusion medicine, bridging the two disciplines together with his work. His accomplishments include the definition of neonatal alloimmune thrombocytopenic purpura, post-transfusion purpura, and quinine-induced hemolytic-uremic syndrome as distinct clinical entities, characterization of the molecular basis for many platelet-specific antigens and contributions to the understanding and diagnosis of various forms of drug-induced immune thrombocytopenia.
Dr. Aster has served as an active member of ASH since 1964, contributing scientific content to every annual meeting since joining the Society. He has also served as Chair of the Scientific Subcommittee on Immunohematology, Councillor of the Executive Committee, member of the Awards Committee, and Associate Editor of Blood. Dr. Aster has authored more than 300 scientific papers, which have been published in the world's premier scientific and clinical journals, including 43 manuscripts published in Blood. He has been honored with the prestigious NIH Merit Award, the Milwaukee Academy of Medicine Distinguished Service Award, the American Association of Blood Banks Bernard Fantus Award Lifetime Achievement Award, and the America's Blood Centers Thomas F. Zuck Lifetime Achievement Award. In addition to his receipt of numerous honors and awards, Dr. Aster has also served as a mentor to countless young investigators who have gone on to have illustrious careers in transfusion medicine.
"Drs. Ginsburg and Aster have made remarkable advances in hematology and the Society is honored to award them with the Stratton Medal for their contributions to the field," said ASH President Armand Keating, MD, of Princess Margaret Hospital in Toronto. "Their achievements have advanced our understanding of how genes play an important role in inherited disease and have led to safer blood transfusions that have saved countless lives around the world."
Drs. Ginsburg and Aster will accept their awards at 9:30 a.m. ET on Tuesday, December 11, during the 54th ASH Annual Meeting and Exposition in Atlanta.
###
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
ASH honors David Ginsburg, M.D., and Richard Aster, M.D., with 2012 Henry M. Stratton MedalPublic release date: 27-Aug-2012 [ | E-mail | Share ]
Contact: Claire Gwayi-Chore cgwayi-chore@hematology.org 202-776-0544 American Society of Hematology
The Henry M. Stratton Medal is named after the late Henry Maurice Stratton, co-founder of Grune and Stratton, the medical publishing house that first published ASH's journal Blood. The prize honors senior investigators whose contributions to hematology are well-recognized and have taken place over a period of several years. This year, for the first time, the Stratton Medal will be awarded to two individuals, one in basic research and the other in clinical/translational research. Dr. Ginsburg will receive the 2012 Stratton Medal for Basic Research for his many seminal scientific contributions in characterizing the molecular and genetic basis of inherited bleeding and clotting disorders. Dr. Aster will receive the 2012 Stratton Medal for Clinical/Translational Research for his many breakthroughs in platelet immunology, mainly in drug-induced antibodies, human leukocyte antigen anti-platelet antibodies, and neonatal thrombocytopenia.
Dr. Ginsburg is the James V. Neel Distinguished University Professor of Internal Medicine, Human Genetics, and Pediatrics at the University of Michigan and an Investigator of the Howard Hughes Medical Institute. Dr. Ginsburg has dedicated his medical career to understanding the clotting system and has made many contributions to the field of hematology, including identifying the genetic basis of numerous clotting disorders, such as thrombotic thrombocytopenic purpura (TTP), combined deficiency of Factor V and Factor VIII, and von Willebrand disease (VWD). Beginning with the cDNA cloning of VWF in 1985, Dr. Ginsburg and his colleagues demonstrated how different mutations in the VWF gene resulted in the variable subtypes of VWD, a focus which also led to his group's identification and cloning of the ADAMTS13 gene as the cause of TTP.
A member of ASH since 1985, Dr. Ginsburg has served in numerous roles within the Society, including serving as Chair of the Committee on Scientific Affairs, Councillor on the Executive Committee, and a member of the Scientific Subcommittee on Hemostasis (now the Scientific Committee on Hemostasis) and the Scientific Committee on Thrombosis and Vascular Biology.
The quality and impact of Dr. Ginsburg's research have been recognized by numerous prestigious honors and awards. In addition to receiving ASH's 2000 E. Donnall Thomas Lecture and Prize, Dr. Ginsburg is an inductee of the Institute of Medicine and National Academy of Sciences and has been honored with the National Institutes of Health (NIH) Merit Award, the American Heart Association Distinguished Scientists Award, and the American Society for Clinical Investigators ASCI/ Stanley J. Korsmeyer Award. Dr. Ginsburg's scientific contributions are only a part of his overall impact on the field of hematology. Another important facet of his contributions is evidenced by the numerous scientists and clinicians that he has mentored over the years, many of whom have made remarkable discoveries in hematology.
Dr. Aster is a Professor of Medicine at the Medical College of Wisconsin and Senior Investigator at the Blood Research Institute of the Blood Center of Wisconsin. As the CEO of the BloodCenter for more than 25 years, Dr. Aster transformed the then local Blood Center of Southeastern Wisconsin into one of the world's premier academic hematology and transfusion medicine research institutes and the top NIH-funded blood center in the country.
During his more than 40-year career Dr. Aster has been continuously recognized as a scientific leader in hematology and transfusion medicine, bridging the two disciplines together with his work. His accomplishments include the definition of neonatal alloimmune thrombocytopenic purpura, post-transfusion purpura, and quinine-induced hemolytic-uremic syndrome as distinct clinical entities, characterization of the molecular basis for many platelet-specific antigens and contributions to the understanding and diagnosis of various forms of drug-induced immune thrombocytopenia.
Dr. Aster has served as an active member of ASH since 1964, contributing scientific content to every annual meeting since joining the Society. He has also served as Chair of the Scientific Subcommittee on Immunohematology, Councillor of the Executive Committee, member of the Awards Committee, and Associate Editor of Blood. Dr. Aster has authored more than 300 scientific papers, which have been published in the world's premier scientific and clinical journals, including 43 manuscripts published in Blood. He has been honored with the prestigious NIH Merit Award, the Milwaukee Academy of Medicine Distinguished Service Award, the American Association of Blood Banks Bernard Fantus Award Lifetime Achievement Award, and the America's Blood Centers Thomas F. Zuck Lifetime Achievement Award. In addition to his receipt of numerous honors and awards, Dr. Aster has also served as a mentor to countless young investigators who have gone on to have illustrious careers in transfusion medicine.
"Drs. Ginsburg and Aster have made remarkable advances in hematology and the Society is honored to award them with the Stratton Medal for their contributions to the field," said ASH President Armand Keating, MD, of Princess Margaret Hospital in Toronto. "Their achievements have advanced our understanding of how genes play an important role in inherited disease and have led to safer blood transfusions that have saved countless lives around the world."
Drs. Ginsburg and Aster will accept their awards at 9:30 a.m. ET on Tuesday, December 11, during the 54th ASH Annual Meeting and Exposition in Atlanta.
###
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Online dating can be a minefield. There are apps and even flameless candles that can help.
By Andrew Kardon, Techlicious
Since the advent of the Internet, online and dating have been courting each other in a web of matchmaking merriment. Sure, online dating sites have brought?lots of people together, as well as created countless Dates from Hell, but technology also provides some pretty powerful tools to protect and improve the overall act of dating.
It can be a real jungle out there, so read on for the must-have dating technology:!
It's a matter of trust
Looks have always been deceiving, but in today's crazy dating scene, pretty much anything goes. So how do you know if you can trust that perfectly dressed guy with the chiseled jaw who insists on walking you home? Sites like BeenVerified.com can offer instant background checks on individuals, by culling together all their public records. With mobile apps for iPhone or Android, you can even check up on your date while you're still on your date.
Honestly Now!
Does this dress make me look fat? Post up your burning question (and a photo, if appropriate) to Honestly Now! and experts in the topic, along with other Honestly Now! users, will give you brutally honest answers. Honestly Now! is free to use, but the advice is priceless.
Tanita
Just breathe
Wondering why your date's sitting so far away from you? Are flowers wilting at your mere presence? Could be that someone needs a breath mint. Still not sure? Then you definitely need to get your hands on Tanita's FitScan Breath Checker ($34.95 on amazon.com). Small enough to fit into your pocket, this discrete device measures your level of bad breath in just nine seconds! How does it do it? With science! When you exhale, the device calculates the amount of volatile sulfur compounds (VSCs) that are given off by bacteria.
Something suddenly just came up
How many times have you asked a friend to be your dating lifeline? You know, have them call you an hour into your date to see how it's going and basically give you an "out" if you're having an awful time. "Oh, my God. It's my mom. Her dog just ate her car keys and she needs a ride to the vet. I'm so sorry but I've gotta run..." If you've got the friend to help you regularly, that's great. But if you don't or you're just sick of asking, then check out the Bad Date Rescue app (free on iTunes), brought to you by the online dating experts over at eHarmony. You can set up your "rescue" well in advance, or quickly activate one to start in a matter of seconds or minutes with a touch of a button.
Call me, maybe
Nothing like giving a guy a fake phone number at the end of the evening. But what if you kind of like the guy but aren't sure? You could end up with a total creep who now knows your number, or he could've been "the one" if only you had given him your real number. Well, there are plenty of ways to use anonymous phone numbers, such as the iPhone app Burner ($1.99 on iTunes), which instantly lets you create a disposable phone number. Each number is a new private line that masks your real line and works just like a regular number. Ready to dump that chump? Just "burn" the number and you'll never hear from him again.
Energizer
Flame on
Nothing sets the mood for a romantic evening like lighting some candles. There's just something about the flickering of the flame and the pleasing scents they gave off. But why risk knocking one over in a fit of passion, or passing out with your hottie and forgetting to blow out the candle?
There are a slew of flameless wax candles available now, but we especially like this realistic-looking Beeswax Pillar made by Energizer (available this fall). It's completely safe and even includes a timer to shut off after 4, 6 or 8 hours. Romance without the danger!
As technology continues to advance, you just know companies will be doing their best to improve your dating life. Today's dating tools are a great start, but what do tomorrow's hold? Perhaps a Kissing Machine that lets you kiss someone halfway around the world or an Intimacy Dress that becomes transparent based on your emotions. For now, we'll just be sure to have the Hotels.com app handy on our phone. Y'know... just in case.
DIY Network's Rob Van Winkle, aka Vanilla Ice, shares age-appropriate gizmos that will give your kids an edge as they head back to school, including a solar-powered backpack and a pen that is also an audio recorder.
?
More stories on Techlicious:
Get the free daily Techlicious Newsletter or chat with Techlicious on?Facebook.
My family takes a lot of road trips. With many friends and family members within a day?s driving distance from our home in West Virginia, we?re on the road quite a bit.
![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
Public release date: 28-Aug-2012
Share ] 
